GENE Share Price

Open 1.20 Change Price %
High 1.28 1 Day 0.02 1.68
Low 1.19 1 Week -0.09 -6.92
Close 1.21 1 Month -0.16 -11.68
Volume 395502 1 Year -1.63 -57.39
52 Week High 3.25
52 Week Low 0.00
GENE Important Levels
Resistance 2 1.29
Resistance 1 1.26
Pivot 1.23
Support 1 1.16
Support 2 1.13
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Genetic Technologies Ltd (NASDAQ: GENE)

GENE Technical Analysis 5
As on 9th Dec 2016 GENE Share Price closed @ 1.21 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.02 & Strong Sell for SHORT-TERM with Stoploss of 1.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
GENE Target for December
1st Target up-side 3.09
2nd Target up-side 3.73
3rd Target up-side 4.36
1st Target down-side 1.29
2nd Target down-side 0.65
3rd Target down-side 0.02
Genetic Technologies Ltd ( NASDAQ USA Symbol : GENE )
Sector : N/AIndustry:N/AFull Time Employees:N/ABusiness Summary Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of DNA based genetic tests for cancer predisposition, including brea And Other Stocks in Same Sector
GENE
1.21 0.02 (1.68 %)
LT : Strong Sell
ST : Strong Sell
GENE Other Details
Segment EQ
Market Capital 52116412.00
Sector N/AIndustry:N/AFull Time Employees:N/ABusiness Summary Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of DNA based genetic tests for cancer predisposition, including brea
Industry N/AFull Time Employees:N/ABusiness Summary Genetic Technologies Limited provides genetic testin
Offical website http://www.gtglabs.com
GENE Address
GENE
60-66 Hanover Street
Fitzroy, VIC 3065
Australia
Phone: 61 3 8412 7000
Fax: 61 3 8412 7040
Interactive Technical Analysis Chart Genetic Technologies Ltd ( GENE NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Genetic Technologies Ltd
GENE Business Profile
Genetic Technologies Limited (GTG) is engaged the provision of genetic testing services. The Company also conducts out-licensing program in respect of its non-coding deoxyribonucleic acid technology and supports a late-stage research project. The Company operates in three segments: Operations, Licensing and Research. The principal geographic segments of the Company include Australia, with the Company�s headquarters being located in Melbourne in the State of Victoria. The Operations segment includes the provision of a range of genetic testing services. The Licensing segment includes the out-licensing of the Group�s non-coding technology. The Research segment includes the undertaking of a range of research and development projects in the field of genetics and related areas. During the fiscal year ended June 30, 2012, the Company launched its new, predictive risk test, BREVAGen. BREVAGen is the clinically validated breast cancer predictive risk assessment tool.